Skip to main content

and
  1. No Access

    Article

    Bortezomib suppresses the growth of leukemia cells with Notch1 overexpression in vivo and in vitro

    Bortezomib has been widely used in the treatment of various cancers; however, its exact mechanisms of action are not fully understood, particularly in acute T lymphoblast leukemia (T-ALL). Here, we visualize t...

    Chongmei Huang, **aoxia Hu, Libing Wang, Shuqing Lü in Cancer Chemotherapy and Pharmacology (2012)